Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Alzheimer Disease, Late Onset
Interventions
BIOLOGICAL

BCG vaccine

Three intra-dermal vaccinations over a period of one year.

Trial Locations (1)

Unknown

Department of Neurology, Hadassah medical Center, Jerusalem

All Listed Sponsors
collaborator

Hebrew University of Jerusalem

OTHER

lead

Tamir Ben-Hur

OTHER